Kim Smith-Whitley

Chief Tech/Sci/R&D Officer presso GLOBAL BLOOD THERAPEUTICS, INC.

63 anni

Consumer Services

Health Technology

Profilo

Kim Smith-Whitley is currently the Director at the Sickle Cell Disease Association of America, Inc. and the Executive VP, Head-Research & Development at Global Blood Therapeutics, Inc. Dr. Smith-Whitley holds a doctorate degree from George Washington University.

Posizioni attive di Kim Smith-Whitley

Società	Posizione	Inizio
GLOBAL BLOOD THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	01/05/2021
Sickle Cell Disease Association of America, Inc.	Director/Board Member	-

Tutte le posizioni attive di Kim Smith-Whitley

Formazione di Kim Smith-Whitley

George Washington University

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kim Smith-Whitley

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Sickle Cell Disease Association of America, Inc.
Global Blood Therapeutics, Inc. Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.	Health Technology